Synapse - Leonard Saltz

Results (19)

Novel methodology of response assessment in hepatocellular carcinoma (HCC) - Assessing response by change in tumor enhancement in distinction from conventional means

Meeting Abstract

Wang, L.; Abou-Alfa, G. K.; Liu, F.; Saltz, L. B.; Kalaigian, J.; Zhao, B.; Colville, J.; Nyoro, J.; Schwartz, B.; Schwartz, L.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)

Meeting Abstract

Saltz, L. B.; Niedzwiecki, D.; Hollis, D.; Goldberg, R. M.; Hantel, A.; Thomas, J. P.; Fields, A. L. A.; Carver, G.; Mayer, R. J.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Cardiac toxicity of 5FU: Does prophylactic telemetry monitoring of patients at increased risk for cardiac toxicity improve safety? A 10-year experience

Meeting Abstract

Pizzolato, J.; Baum, M. S.; Steingart, R. M.; Gonen, M.; Minsky, B. D.; Saltz, L. B.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

A case for time to tumor progression (TTP) as the primary (1 degrees) efficacy endpoint in 1(st)-line metastatic colorectal cancer (MCRC) therapy: Correlation of TTP and overall survival (OS)

Meeting Abstract

Mille, L. L.; Elfring, G. L.; Gruia, G.; Hirawat, S.; Douillard, J. Y.; Saltz, L. B.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Statin use may increase the pathologic complete response rate after neoadjuvant chemoradiation for rectal cancer

Meeting Abstract

Katz, M. S.; Minsky, B. D.; Saltz, L. B.; Riedel, E.; Chessin, D.; Guillem, J. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Changing physician practice and introduction of treatment guidelines for colorectal cancer: An analysis of 162,477 patients

Meeting Abstract

Greene, F. L.; Saltz, L. B.; Stewart, A. K.; Gay, E. G.
Annals of Surgical Oncology (2004)

Fulltext@MSK | Save

Variability in response definition and confirmation practices in randomized phase II and III trials in colorectal cancer

Meeting Abstract

Chung, K. Y.; Saltz, L. B.; Schwartz, L. H.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Clinical assessment following preoperative combined modality therapy (CMT) for rectal carcinoma does not accurately predict pathologic response: A prospective analysis

Meeting Abstract

Chessin, D. B.; Shia, J.; Mazumdar, M.; Moore, H. G.; Paty, P.; Saltz, L.; Minsky, B.; Cohen, A. M.; Wong, W. D.; Guillem, J. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum